We want to ensure optimum use of our website for you, and to continually improve our website. Therefore, we work with selected partners (e.g. Pardot). You can revoke your voluntary consent at any time. You can find further information and setting options under „Configure“ and in our data protection information.
PRESS RELEASE Stockholm, Sweden, May 8, 2007 Elekta Neuromag Oy, the Finnish subsidiary of the Swedish Elekta Group, and Innokas Medical Oy, a Finnish private company, have signed an agreement covering production of the Elekta Neuromag® magnetoencephalography (MEG) system. The Elekta Neuromag MEG system is used for non-invasive real-time measurements of brain activity at leading research institutions and hospitals around the world. The production, including the employees involved, will be transferred to Innokas Medical during 2007.
Elekta is reinforcing its operations in the MEG business area due to the changing market situations and the increased need for Elekta’s MEG technology. By outsourcing its MEG production to Innokas Medical, Elekta will get the benefit of a flexible and expert medical equipment production partner, while keeping the overall technical responsibility of the MEG system towards the customer. Elekta will continue to invest in innovation and fulfilling the customers' needs in the MEG area.
For Innokas Medical, this agreement is an important step in its growth strategy. It will strengthen the company's position as a leading medical equipment contract manufacturer in Finland.
“Non-invasive, real-time brain mapping and monitoring is considered as one of the most exciting developments in neuroscience today and the list of new applications for MEG is steadily growing and the number of installations are increasing,” said Tomas Puusepp, President and CEO of Elekta. ”Elekta is the only MEG vendor on the market with the financial stability needed to be committed to the long-term development of MEG technology and our production outsourcing agreement with Innokas Medical further strengthen our ability to serve neuroscience centers around the world with leading MEG technology.”